Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-27
2008-05-27
Coleman, Brenda L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S260100, C514S234200, C514S218000, C544S278000, C544S117000, C544S231000, C540S575000, C540S492000, C540S460000, C540S504000
Reexamination Certificate
active
07378411
ABSTRACT:
The present invention relates to thienopyrimidinone compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.
REFERENCES:
patent: 5124331 (1992-06-01), Arita et al.
patent: 6136812 (2000-10-01), Chenard et al.
patent: 884 310 (1998-12-01), None
patent: WO 01 30768 (2001-05-01), None
patent: WO 01 74344 (2001-10-01), None
Coleman, P.J.; Fraley, M. E.; Expert. Opin. Ther. Patents; 2004; 14(12);1659-1667.
Gadad et al., Arzneimittel-Forschung, 1996, 46(10), 981-985.
Cancer Management: A Multidisciplinary Approach, Publishers of Oncology, 2005-2006, 9th Edition, Chapter 26, 615-638.
Colorectal Cancer Coalition, <http://www.fightcolorectalcancer.org/patients/diagnosis/rctreatment.htm> downloaded from the internet Nov. 27, 2006.
Cancer Research 64, pp. 3276-3280, May 1, 2004, by R. Sakowicz, et al.
Kim, KS et al., Bioorganic & Medicinal Chemistry Letters 16, pp. 3937-3942 (2006), “Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors”.
Fraley Mark E.
Hartman George D.
Hoffman William F.
Beeler Nicole M.
Coleman Brenda L.
Merck & Co. , Inc.
Moore Susanna
Muthard David A.
LandOfFree
Substituted thienopyrimidinones as a mitotic kinesin inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted thienopyrimidinones as a mitotic kinesin inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted thienopyrimidinones as a mitotic kinesin inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807191